Cue Biopharma, Inc.
Last verified 2026-05-21. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $30.0Mattributed |
|---|---|
| Latest round | Funding round, $30.0M, 2026-05-04attributed |
| Founded | 2014 |
| Headquarters | Boston, MA |
| Industry | biotechnology |
| Stage | unknown |
| Website | cuebiopharma.com |
Cue Biopharma is a clinical-stage precision immunology company developing biologics aimed at functional cures for immune disorders with high unmet need. It targets patients with autoimmune conditions that current therapies only manage. Its approach modulates the specific immune cells driving disease rather than broadly suppressing immunity.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-05-04 | Funding round | $30.0M | undisclosed |
Detected tech stack
Nginx, WordPress, Modernizr, Yoast SEO 23.4, Google Analytics, Google Tag Manager, Site Kit 1.179.0, jQuery Migrate 3.4.1, DoubleClick Floodlight, WordPress Block Editor, WP Engine, MongoDB
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $30.0M | attributed | sec-edgar named as publisher. No document URL on file. |
| Total raised $30.0M | attributed | sec-edgar named as publisher. No document URL on file. |
| Company existence | self-reported | cuebiopharma.com, read 2026-05-21 |
| Description | self-reported | cuebiopharma.com, read 2026-05-21 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $30.0M, 2026-05-04 → Funding round, $30.0M, 2026-05-04, sec-edgar, No document URL on file | Latest round | seed, $30.0M, 2026-05-04 → Funding round, $30.0M, 2026-05-04 | sec-edgar, No document URL on file |
Records begin 2026-09-24. All changes